Variable | Frequency (N) | Percentage | |
Gender | |||
| Male | 430 | 16.3% |
| Female | 2212 | 83.7% |
Age | |||
| 18 - 22 | 818 | 30.96% |
| 23 - 35 | 1114 | 42.17% |
| 36 - 50 | 561 | 21.23% |
| More than 50 | 149 | 5.64% |
Profession | |||
| Jobless | 810 | 30.66% |
| Student | 715 | 27.06% |
| Teacher | 475 | 17.98% |
| Self-employment | 316 | 11.96% |
| Medical Field | 162 | 6.13% |
| Other | 164 | 6.21% |
Chronic Disease | |||
| Yes | 307 | 11.62% |
| No | 2335 | 88.38% |
Smoking | |||
| Yes | 1110 | 42.01% |
| No | 1532 | 57.99% |
Infected | |||
| Yes | 1205 | 45.61% |
| No | 1437 | 54.39% |
Infection Symptoms | |||
| No Symptoms | 69 | 5.73% |
| Mild/Moderate | 998 | 82.82% |
| Severe Symptoms | 138 | 11.45% |
Source of information about the vaccine | |||
| Social media | 1466 | 31.83% |
| TV, Magazines, and chats | 884 | 19.19% |
| Scientific Publications | 1222 | 26.53% |
| Health Workers | 1043 | 22.45% |
Vaccinated | |||
| Yes | 1860 | 70.4% |
| No | 782 | 29.6% |
Willingness to take the vaccine | |||
| Yes | 185 | 23.66% |
| No | 597 | 76.34% |
Vaccine Symptoms | |||
| No Symptoms | 486 | 26.13% |
| Mild/Moderate | 1297 | 69.73% |
| Severe Symptoms | 77 | 4.14% |
Vaccine type | |||
| Pfizer | 1494 | 80.32% |
| AstraZeneca | 294 | 15.81% |
| Other | 72 | 3.87% |
Number of doses | |||
| One dose | 307 | 16.5% |
| Two doses | 1426 | 76.67% |
| Three doses | 127 | 6.83% |
Willingness to take next dose | |||
| Yes | 1559 | 83.82% |
| No | 301 | 16.18% |